NMS-293 is a PARP-1 inhibitor in early clinical development at Nerviano Medical Sciences for the treatment of advanced or metastatic solid tumors, including diffuse glioma and glioblastoma.
For research use only. We do not sell to patients.
Fast & Safe Delivery Worldwide
Safety and Security
Copyright 2015-2022 武汉永璨生物科技有限公司 版权所有 | 鄂ICP备17005301号-1